Abbott Laboratories

XNYSHealth care

Last traded price · USD

$115.50

+5.58%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: $112.65
Previous close: $109.40
Volume: 12.7M
Day's high: $116.22
Day's low: $112.12

In brief

Abbott Laboratories is a health care company listed on the New York Stock Exchange, valued at about $199.86B.
Its shares closed at $115.51 on 4 Nov 2026, down 8.2% over the past year.
From India you can buy ABT in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Abbott Laboratories (ABT) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole ABT share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade ABT options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $115.51 was 11.0% above its 50-day average ($104.05) and 13.8% above its 200-day average ($101.54). It has closed above the 200-day for 10 sessions, since 22 Oct 2026. The 50-day average crossed above the 200-day on 16 Sep 2026, 35 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +17.7% (SPY −1.6%, XLV +13.5%). 3 months: +9.3% (SPY −0.4%, XLV +15.5%). 1 year: −8.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ABT, SPY and XLV · as of 4 Nov 2026
Rose 5.6% on 4 Nov 2026
The 4 Nov 2026 gain of 5.6% was 4.6× its average daily move of 1.2% over the past year, and its largest one-day gain since 16 Jul 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
RSI(14) at 73.5, 70 or above
The 14-session relative strength index closed at 73.5 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
67% of the way up its 52-week range
Closed at $115.51 on 4 Nov 2026: 12.5% below the 52-week high of $132.03 (18 Nov 2025) and 40.9% above the low of $81.97 (11 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+17.7%

6 months+33.8%

1 year−8.2%

5 years−10.5%

Newswire

About

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Website

Notable moves

July 16, 2026
+10.71%
January 22, 2026
−10.04%
July 17, 2025
−8.52%

Newswire

About

Website

Notable moves

July 16, 2026
+10.71%
January 22, 2026
−10.04%
July 17, 2025
−8.52%

Abbott Laboratories

XNYSHealth care

Last traded price · USD

$115.50

+5.58%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: $112.65
Previous close: $109.40
Volume: 12.7M
Day's high: $116.22
Day's low: $112.12

In brief

Abbott Laboratories is a health care company listed on the New York Stock Exchange, valued at about $199.86B.
Its shares closed at $115.51 on 4 Nov 2026, down 8.2% over the past year.
From India you can buy ABT in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Abbott Laboratories (ABT) shares from India?

Do I need the price of a whole ABT share to invest?

How much can I invest in US stocks in a year?

Can I trade ABT options or futures?

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $115.51 was 11.0% above its 50-day average ($104.05) and 13.8% above its 200-day average ($101.54). It has closed above the 200-day for 10 sessions, since 22 Oct 2026. The 50-day average crossed above the 200-day on 16 Sep 2026, 35 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +17.7% (SPY −1.6%, XLV +13.5%). 3 months: +9.3% (SPY −0.4%, XLV +15.5%). 1 year: −8.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ABT, SPY and XLV · as of 4 Nov 2026
Rose 5.6% on 4 Nov 2026
The 4 Nov 2026 gain of 5.6% was 4.6× its average daily move of 1.2% over the past year, and its largest one-day gain since 16 Jul 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
RSI(14) at 73.5, 70 or above
The 14-session relative strength index closed at 73.5 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
67% of the way up its 52-week range
Closed at $115.51 on 4 Nov 2026: 12.5% below the 52-week high of $132.03 (18 Nov 2025) and 40.9% above the low of $81.97 (11 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+17.7%

6 months+33.8%

1 year−8.2%

5 years−10.5%

Newswire

About

Website

Notable moves

July 16, 2026
+10.71%
January 22, 2026
−10.04%
July 17, 2025
−8.52%

Newswire

About

Website

Notable moves

July 16, 2026
+10.71%
January 22, 2026
−10.04%
July 17, 2025
−8.52%

Abbott Laboratories

Abbott Laboratories in brief

Above its 50- and 200-day averages

Behind SPY and its sector fund XLV over 1 year

Rose 5.6% on 4 Nov 2026

RSI(14) at 73.5, 70 or above

67% of the way up its 52-week range

Abbott Laboratories

Abbott Laboratories in brief

Above its 50- and 200-day averages

Behind SPY and its sector fund XLV over 1 year

Rose 5.6% on 4 Nov 2026

RSI(14) at 73.5, 70 or above

67% of the way up its 52-week range